Author details

Full Name

Joseph P Menetski

Affiliation

The Foundation for the National Institutes of Health

ORCID

Career Start Year

1985

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36730407	The NIH-led research response to COVID-19.	Science	2023
35030631	Sleep and circadian informatics data harmonization: a workshop report from the Sleep Research Society and Sleep Research Network.	Sleep	2022
33115823	A Biomarker-Centric Approach to Drug Discovery and Development: Lessons Learned from the Coronavirus Disease 2019 Pandemic.	J Pharmacol Exp Ther	2021
34495876	Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines-Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials.	Crit Care Med	2021
34056520	Remote Cardiac Safety Monitoring through the Lens of the FDA Biomarker Qualification Evidentiary Criteria Framework: A Case Study Analysis.	Digit Biomark	2021
30869772	Establishing the Link Between Lean Mass and Grip Strength Cut Points With Mobility Disability and Other Health Outcomes: Proceedings of the Sarcopenia Definition and Outcomes Consortium Conference.	J Gerontol A Biol Sci Med Sci	2020
33152278	Accelerated Preclinical Paths to Support Rapid Development of COVID-19 Therapeutics.	Cell Host Microbe	2020
32409759	Remote digital monitoring in clinical trials in the time of COVID-19.	Nat Rev Drug Discov	2020
30648736	The Foundation for the National Institutes of Health Biomarkers Consortium: Past Accomplishments and New Strategic Direction.	Clin Pharmacol Ther	2019
32095769	Traditional and Digital Biomarkers: Two Worlds Apart?	Digit Biomark	2019
31367046	The FNIH Biomarkers Consortium embraces the BEST.	Nat Rev Drug Discov	2019
29167393	What evidence do we need for biomarker qualification?	Sci Transl Med	2017
24126144	Genomic and systems approaches to translational biomarker discovery in immunological diseases.	Drug Discov Today	2014
21475673	Evaluation of early biomarkers of muscle anabolic response to testosterone.	J Cachexia Sarcopenia Muscle	2011
22023915	Evaluation of glyceraldehyde-3-phosphate, prolylpeptidyl isomerase A, and a set of stably expressed genes as reference mRNAs in urate crystal inflammation.	BMC Res Notes	2011
21396468	Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis.	Osteoarthritis Cartilage	2011
18403781	Identification of transforming growth factor beta1-driven genetic programs of acute lung fibrosis.	Am J Respir Cell Mol Biol	2008
18522745	Identification of novel monosodium urate crystal regulated mRNAs by transcript profiling of dissected murine air pouch membranes.	Arthritis Res Ther	2008
18346052	Deficiency in cytosolic malic enzyme does not increase acetaminophen-induced hepato-toxicity.	Basic Clin Pharmacol Toxicol	2008
17870246	Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses.	Neuroscience	2007
10779384	Analysis of a mutation in phosphodiesterase type 4 that alters both inhibitor activity and nucleotide selectivity.	Mol Pharmacol	2000
10713070	The structure of the nuclear factor-kappaB protein-DNA complex varies with DNA-binding site sequence.	J Biol Chem	2000
7584151	V-D-J rearrangements at the T cell receptor delta locus in mouse thymocytes of the alpha beta lineage.	Immunity	1995
1313336	V(D)J recombination in mouse thymocytes: double-strand breaks near T cell receptor delta rearrangement signals.	Cell	1992
1350278	The physical and enzymatic properties of Escherichia coli recA protein display anion-specific inhibition.	J Biol Chem	1992
1356077	V(D)J recombination: broken DNA molecules with covalently sealed (hairpin) coding ends in scid mouse thymocytes.	Cell	1992
1490345	Double-strand breaks associated with V(D)J recombination at the TCR delta locus in murine thymocytes.	Curr Top Microbiol Immunol	1992
1701258	V(D)J recombination activity in lymphoid cell lines is increased by agents that elevate cAMP.	Proc Natl Acad Sci U S A	1990
2404275	Stable DNA heteroduplex formation catalyzed by the Escherichia coli RecA protein in the absence of ATP hydrolysis.	Proc Natl Acad Sci U S A	1990
2179566	Biochemical properties of the Escherichia coli recA430 protein. Analysis of a mutation that affects the interaction of the ATP-recA protein complex with single-stranded DNA.	J Mol Biol	1990
2673351	Enhancement of Escherichia coli RecA protein enzymatic function by dATP.	Biochemistry	1989
3284580	Properties of the high-affinity single-stranded DNA binding state of the Escherichia coli recA protein.	Biochemistry	1988
3818586	Transfer of recA protein from one polynucleotide to another. Kinetic evidence for a ternary intermediate during the transfer reaction.	J Biol Chem	1987
3818587	Transfer of recA protein from one polynucleotide to another. Effect of ATP and determination of the processivity of ATP hydrolysis during transfer.	J Biol Chem	1987
3981638	Interaction of recA protein with single-stranded DNA. Quantitative aspects of binding affinity modulation by nucleotide cofactors.	J Mol Biol	1985

1 - 35 of 35

Sarah Keegan

Institute for Systems Genetics, New York University Langone Medical Center

Career Start Year 2013

Number of shared co-authors 0

Matthew D Sekedat

Columbia University

Career Start Year 2004

Number of shared co-authors 0

Scott H Harrison

North Carolina Agricultural and Technical State University

Career Start Year 2002

Number of shared co-authors 0

Daniel J Mazur

Feinberg School of Medicine, Northwestern University

Career Start Year 1999

Number of shared co-authors 0

Chuan He

Institute of Hematology, West China Hospital of Sichuan University

Career Start Year 1999

Number of shared co-authors 0

Krishna M Sinha

The University of Texas MD Anderson Cancer Center

Career Start Year 1998

Number of shared co-authors 0

Kostantin Kiianitsa

University of Washington

Career Start Year 1997

Number of shared co-authors 0

Barry Merriman

David Geffen School of Medicine, University of California los angeles

Career Start Year 1997

Number of shared co-authors 0

Mojca Ben??ina

National Institute of Chemistry

Career Start Year 1994

Number of shared co-authors 0

Hee-Won Park

Kangwon National University College of Medicine

Career Start Year 1993

Number of shared co-authors 1

Milton H Werner

Inhibikase Therapeutics Inc.

Career Start Year 1991

Number of shared co-authors 0

Jong-Il Kim

Genomic Medicine Institute, Medical Research Center, Seoul National University

Career Start Year 1989

Number of shared co-authors 0

Philip J R Day

University of Cape Town

Career Start Year 1988

Number of shared co-authors 0

Satyajit Ray

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1986

Number of shared co-authors 0

Aled M Edwards

University of Toronto

Career Start Year 1984

Number of shared co-authors 0

Opher Gileadi

Structural Genomics Consortium Karolinska Institute Stockholm Sweden.

Career Start Year 1984

Number of shared co-authors 0

Henry Rodriguez

Office of Cancer Clinical Proteomics Research, National Cancer Institute

Career Start Year 1983

Number of shared co-authors 2

Walter J Chazin

and Center for Structural Biology, Vanderbilt University

Career Start Year 1982

Number of shared co-authors 0

Bennett Van Houten

UPMC-Hillman Cancer Center, University of Pittsburgh

Career Start Year 1982

Number of shared co-authors 0

Robert M Stephens

Frederick National Laboratory for Cancer Research, Inc.

Career Start Year 1980

Number of shared co-authors 1

Kalappa Muniyappa

Indian Institute of Science

Career Start Year 1979

Number of shared co-authors 0

Michael Brenowitz

Albert Einstein College of Medicine

Career Start Year 1979

Number of shared co-authors 0

Peter J Munson

and Blood Institute, National Institutes of Health

Career Start Year 1978

Number of shared co-authors 3

George M Church

Harvard Medical School

Career Start Year 1977

Number of shared co-authors 1

John A Tainer

The University of Texas MD Anderson Cancer Center

Career Start Year 1975

Number of shared co-authors 0

Hiroshi Handa

Center for Future Medical Research, Tokyo Medical University

Career Start Year 1975

Number of shared co-authors 0

Norma Neff

Stanford University

Career Start Year 1974

Number of shared co-authors 0

Ronald W Davis

Stanford University

Career Start Year 1968

Number of shared co-authors 1

Lloyd M Smith

University of Wisconsin-Madison College of Letters and Sciences

Career Start Year 1964

Number of shared co-authors 2

David Schlessinger

NIH/National Institute of Ageing

Career Start Year 1960

Number of shared co-authors 5

row(s) 1 - 30 of 30

Stacey J Adam

Foundation for the National Institutes of Health

Co-authored papers 2

Ruxandra Draghia-Akli

The Janssen Pharmaceutical Companies of Johnson & Johnson

Co-authored papers 2

John A T Young

Roche Pharma

Co-authored papers 2

Christopher P Austin

St. George's University Medical School

Co-authored papers 2

Elena S Izmailova

Co-authored papers 2

Melissa A Haendel

American Medical Informatics Association, Oregon Health and Science University, Oregon State University, University of Colorado Anschutz Medical Campus, University of North Carolina at Chapel Hill, University of Wisconsin-Madison

Co-authored papers 1

Eric B Fauman

Co-authored papers 1

Julie A McMurry

University of Colorado - Anschutz Medical Campus

Co-authored papers 1

Elliott M Antman

Co-authored papers 1

Shalender Bhasin

Brigham and Women's Hospital, Harvard Medical School

Co-authored papers 1

Connor J Smith